Dr. Ludwig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2009 - 2012
- Loyola University Chicago Stritch School of MedicineClass of 2009
Certifications & Licensure
- TX State Medical License 2011 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Roles: Sponsor-Investigator, Contact
- Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsLarotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other PediatricFusion-Positive Solid Tumors (Children's Oncology Group ADVL1823).Theodore W Laetsch, Stephan Voss, Kathleen Ludwig, David Hall, Donald A Barkauskas
Journal of Clinical Oncology. 2025-04-01 - Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.Hiroto Inaba, David Teachey, Colleen Annesley, Sandeep Batra, Jill Beck
Journal of the National Comprehensive Cancer Network. 2025-02-01 - Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia.Rachel D Harris, Olga A Taylor, M Monica Gramatges, Amy E Hughes, Mark Zobeck
Pharmacotherapy. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: